Cost-effectiveness of rosiglitazone for treatment of type 2 diabetes in Portugal using different methods to model clinical effects

MJ Taylor; A Bagust; João Pereira; S Mendes da Costa; S Beale; A Shearer

Cost-effectiveness of rosiglitazone for treatment of type 2 diabetes in Portugal using different methods to model clinical effects

MJ Taylor , A Bagust , João Pereira, S Mendes da Costa, S Beale, A Shearer

Escola Nacional de Saúde Pública (ENSP)

Research output: Contribution to journal › Meeting Abstract › peer-review

13 Downloads (Pure)

Original language	English
Pages (from-to)	A232
Journal	Value In Health
Volume	9
Issue number	6
Publication status	Published - 1 Jan 2006
Event	ISPOR 9th Annual European Congress - Copenhagen, Denmark Duration: 27 Oct 2006 → 30 Oct 2006 Conference number: 9

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

COST-EFFECTIVENESS OF ROSIGLITAZONEFinal published version, 72.2 KBLicence: Unspecified

Cite this

@article{032dbf8370e54e26834495096b2a5cc2,

title = "Cost-effectiveness of rosiglitazone for treatment of type 2 diabetes in Portugal using different methods to model clinical effects",

author = "MJ Taylor and A Bagust and Jo{\~a}o Pereira and {Mendes da Costa}, S and S Beale and A Shearer",

year = "2006",

month = jan,

day = "1",

language = "English",

volume = "9",

pages = "A232",

journal = "Value In Health",

issn = "1098-3015",

publisher = "Elsevier",

number = "6",

note = "ISPOR 9th Annual European Congress ; Conference date: 27-10-2006 Through 30-10-2006",

}

TY - JOUR

T1 - Cost-effectiveness of rosiglitazone for treatment of type 2 diabetes in Portugal using different methods to model clinical effects

AU - Taylor , MJ

AU - Bagust , A

AU - Pereira, João

AU - Mendes da Costa, S

AU - Beale, S

AU - Shearer, A

N1 - Conference code: 9

PY - 2006/1/1

Y1 - 2006/1/1

UR - https://www.valueinhealthjournal.com/article/S1098-3015(10)63296-2/abstract?code=jval-site

M3 - Meeting Abstract

SN - 1098-3015

VL - 9

SP - A232

JO - Value In Health

JF - Value In Health

IS - 6

T2 - ISPOR 9th Annual European Congress

Y2 - 27 October 2006 through 30 October 2006

ER -

Cost-effectiveness of rosiglitazone for treatment of type 2 diabetes in Portugal using different methods to model clinical effects

UN SDGs

Access to Document

Other files and links

Cite this